Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Church MK Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. 2010 Br. J. Dermatol. pmid:20819087
Hasan AM et al. Phosphoinositide 3-kinase gamma mediates chemotactic responses of human eosinophils to platelet-activating factor. 2010 Int. Immunopharmacol. pmid:20685403
Zhao W et al. [Expression and regulation of pituitary adenylate cyclase-activating polypeptide mRNA in pregnant rat corpus luteum]. 2010 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21038678
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Kordan W et al. Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. 2010 Pol J Vet Sci pmid:21370733
Gao F et al. [The levels of platelet-activating factor and nitric oxide synthase in bronchial asthma at high altitude]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:20979844
Xu CL et al. [Inhibitory effect of TBN on platelet aggregation in rabbit]. 2010 Zhong Yao Cai pmid:21243778
Garcia CC et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. 2010 PLoS Pathog. pmid:21079759
de Souza Carmo EV et al. Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. 2010 PLoS ONE pmid:21082032
Nandy D et al. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. 2010 J. Cell. Mol. Med. pmid:19754670
Borthakur A et al. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. 2010 Inflamm. Bowel Dis. pmid:19714753
Fité R and Borja J Rupatadine and heart rhythm disturbances. 2010 Clin. Pharmacol. Ther. pmid:19727070
Chen S et al. [Induction effect of platelet-activating factor on Src-suppressed C kinase substrate gene expression in rat pulmonary microvascular endothelial cells]. 2010 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:20367900
Leoni G et al. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. 2010 Br. J. Pharmacol. pmid:20331604
Danker K et al. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane. 2010 Br. J. Pharmacol. pmid:20331609
Kajiwara N et al. Activation of human mast cells through the platelet-activating factor receptor. 2010 J. Allergy Clin. Immunol. pmid:20392487
Corl CM et al. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. 2010 Vet. Immunol. Immunopathol. pmid:20359754
Shi C et al. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. 2010 Neurochem. Int. pmid:20362023
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Ritter JM Novel targets and regulatory ordeal by QT interval. 2010 Br J Clin Pharmacol pmid:20406216
Donado E et al. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. 2010 Br J Clin Pharmacol pmid:20406224
Saad MM et al. Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. 2010 Can J Anaesth pmid:19882198
Chen H et al. Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. 2010 Clin Oral Investig pmid:19826843
Sreevidya CS et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. 2010 J. Invest. Dermatol. pmid:19829299
Lautenschläger I et al. A model of the isolated perfused rat small intestine. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19910525
Yang Y et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. 2010 Eur. Respir. J. pmid:19926744
Cureton EL et al. Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. 2010 Shock pmid:19940814
Rieder F et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20299604
Prokosch V et al. Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20592227
Morimoto R et al. Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages. 2010 J. Biol. Chem. pmid:20663880
Balestrieri ML et al. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. 2010 Biochim. Biophys. Acta pmid:20637897
Karasuyama H et al. Role for basophils in systemic anaphylaxis. 2010 Chem Immunol Allergy pmid:20519883
Sanz ML et al. In vitro diagnosis of anaphylaxis. 2010 Chem Immunol Allergy pmid:20519886
Sharma J et al. Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. 2010 Biochemistry pmid:20521843
Cerkiene Z et al. Immune factors in human embryo culture and their significance. 2010 Medicina (Kaunas) pmid:20571290
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
Liu SH et al. Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide. 2010 Chin. Med. J. pmid:20497711
Kuebler WM et al. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. 2010 Cell. Physiol. Biochem. pmid:20502002
Wang L et al. Three new compounds from Morus nigra L. 2010 J Asian Nat Prod Res pmid:20552479
Lu J et al. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. 2010 Pediatr. Res. pmid:20531249
Kim DD et al. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. 2010 Microcirculation pmid:20163539
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Sharif NA and Wiernas TK Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells. 2010 J Ocul Pharmacol Ther pmid:20187806
Metz M et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. 2010 Ann. Allergy Asthma Immunol. pmid:20143651
Xiping Z et al. Effects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitis. 2010 Inflammation pmid:20127399
Shin SH et al. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells. 2010 Cell. Physiol. Biochem. pmid:21063106
Grassi G et al. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. 2010 J. Endocrinol. Invest. pmid:20220291
Binder U et al. The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. 2010 Mol. Microbiol. pmid:19889092
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Peng SY et al. [Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes]. 2010 Yao Xue Xue Bao pmid:21351565